OMB Control No.: 0910-0695
Expiration Date: 3/31/2024
Paperwork Reduction Act Statement: According to the Paperwork Reduction Act of 1995, an agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a valid OMB control number. The valid OMB control number for this information collection is 0910-0695. The time required to complete this portion of the information collection is estimated to average 10 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information.
Send comments regarding this burden estimate or any other aspects of this collection of information, including suggestions for reducing burden to PRAStaff@fda.hhs.gov.
Appendix B
Interview Recruitment Screener
FDA – IDI Screening Questionnaire for Study to Explore Healthcare Providers’ Practices, Perspectives, and Experiences Prescribing/Co-Prescribing Benzodiazepines and Opioids
FINAL
Breakdown of the 30 One-on-One Interviews
9 interviews among primary care physicians (PCPs) who have NOT prescribed MOUD/buprenorphine
3 interviews among PCPs who have prescribed MOUD [i.e., their main practice is general primary care, but they have prescribed MOUD/buprenorphine to patients for opioid use disorder]
2 interviews among PCP specialists in Mental Health who have NOT prescribed MOUD/buprenorphine
2 interviews among PCP specialists/psychiatrists in Mental Health who have prescribed buprenorphine products for OUD in the past 3 months
2 interviews among PCP specialists in Neurology who have NOT prescribed MOUD/buprenorphine
2 interviews among PCP specialist in Emergency Medicine who have NOT prescribed MOUD/buprenorphine
2 interviews among PCP specialists in Pain Medicine (may have prescribed buprenorphine products for OUD in the past 3 months)
2 interviews among PCP specialists in Addiction Medicine who have prescribed buprenorphine products or dispensed methadone for OUD in the past 3 months
2 interviews among primary care nurse practitioners (NPs) who have NOT prescribed MOUD/buprenorphine
2 interviews among primary care physician assistants (PAs) who have NOT prescribed MOUD/buprenorphine
1 interview with a NP specialist in Mental Health who have NOT prescribed MOUD/buprenorphine
1 interview with a PA specialist in Mental Health who have NOT prescribed MOUD/buprenorphine
NOTE TO RECRUITERS:
Please make sure respondents are aware the interview they are being recruited for will last about 60 minutes.
Please recruit 36 healthcare providers in total to ensure we have 30 participants (recruiting 2 extra physicians, 2 extra PAs, and 2 extra NPs).
Introductory Script:
[Hello [Name of HCP from file], /Hello. May I please speak to [name of HCP from file]?]
We are recruiting health care providers for a study sponsored by the U.S. Food and Drug Administration (FDA). The FDA has asked Lake Research Partners (LRP), an independent research company, to conduct 60-minute one-on-one interviews with healthcare providers about benzodiazepine and opioid medications. I work with Schlesinger, the recruiting partner working with LRP, and would like to ask you a few questions to see if you qualify for one of the interviews being conducted.
Select one
Physician (MD, DO) 1
Physician’s Assistant 2
Nurse Practitioner 3
Psychologist 4
None of the above [TERMINATE; MOVE TO INELIGIBLE CLOSING SCRIPT] 5
Total Number of Recruits per Occupation Type Physician (MD, DO) – recruit 26 (including the 2 over-recruits) Physician’s Assistant – recruit 5 (including the 2 over-recruits) Nurse Practitioner – recruit 5 (including the 2 over-recruits) |
Select one
Yes [TERMINATE; MOVE TO INELIGIBLE CLOSING SCRIPT] 1
No 2
Don't know [TERMINATE; MOVE TO INELIGIBLE CLOSING SCRIPT] 3
Select one
Any office, division, or agency within the Department of Health and Human Services (HHS) [ TERMINATE; MOVE TO INELIGIBLE CLOSING SCRIPT] 1
A pharmaceutical company [TERMINATE; MOVE TO INELIGIBLE CLOSING SCRIPT] 2
Neither of the above 3
Select one
Yes, currently 1
Yes, have in the past 2
No 3
Prefer not to answer 4
Select one
Primary care, (family practice, or general, internal, or geriatric medicine) 1
Mental health, psychiatry, geriatric psychiatry, or psychology 2
Neurology/Neurophysiology 3
Emergency Medicine 4
Pain Medicine 5
Addiction Medicine 6
Something else [TERMINATE; MOVE TO INELIGIBLE CLOSING SCRIPT] 7
Don't know [TERMINATE; MOVE TO INELIGIBLE CLOSING SCRIPT] 8
Key to Determine Interview-Type Qualifications
Total Number of Recruits per Practice Area Physician (MD, DO) – recruit 26 (including the 2 over-recruits) Physician’s Assistant – recruit 5 (including the 2 over-recruits) Nurse Practitioner – recruit 5 (including the 2 over-recruits) |
For each option, select one of the following responses:
1 to 4 patients {TERMINATE; MOVE TO INELIGIBLE CLOSING SCRIPT} 1
5 or more patients 2
Does not apply {TERMINATE; MOVE TO INELIGIBLE CLOSING SCRIPT} 3
Benzodiazepines (e.g., Xanax/alprazolam, Valium/diazepam, Klonopin/clonazepam)
Opioid analgesics (e.g., OxyContin/oxycodone, Vicodin/hydrocodone, MS Contin/morphine)
Yes 1
No 2
Prefer not to answer [TERMINATE; MOVE TO INELIGIBLE CLOSING SCRIPT] 3
Select one
Yes 1
No [SKIP TO Q12] 2
Prefer not to answer [TERMINATE; MOVE TO INELIGIBLE CLOSING SCRIPT] 3
Key to Determine Interview-Type Qualifications
|
Select one
Less than 1 year 1
1 to 4 years 2
5 or more years 3
Does not apply 4
Select one
Yes 1
No 2
Prefer not to answer [TERMINATE; MOVE TO INELIGIBLE CLOSING SCRIPT] 3
Key to Determine Interview-Type Qualifications
2 interviews among PCP specialists/psychiatrists who have prescribed MOUD; 2 interviews among PCP specialists in Addiction Medicine who have prescribed MOUD; and 2 interviews among PCP specialists in Pain Medicine who may have prescribed MOUD;
|
Very often 1
Often 2
Sometimes 3
Rarely 4
Select one
Yes 1
No 2
Don't know 3
Prefer not to answer [TERMINATE; MOVE TO INELIGIBLE CLOSING SCRIPT] 4
Select one
Male [RECRUIT 18] 1
Female [RECRUIT 18] 2
Select one
Less than 10 years 1
10-19 years 2
20-29 years 3
30 years or more 4
Prefer not to say 5
Select one
Urban 1
Suburban 2
Rural 3
Insert drop-down list of states
Select one
Key for Recruiters |
||||||||
New England |
Middle Atlantic |
East North Central |
West North Central |
South Atlantic |
East South Central |
West South Central |
Mountain |
Pacific |
CT |
NJ |
IN |
IA |
DE |
AL |
AR |
AZ |
AK |
ME |
NY |
IL |
KS |
DC |
KY |
LA |
CO |
CA |
MA |
PA |
MI |
MN |
FL |
MS |
OK |
ID |
HI |
NH |
|
OH |
MO |
GA |
TN |
TX |
NM |
OR |
RI |
|
WI |
NE |
MD |
|
|
MT |
WA |
VT |
|
|
ND |
NC |
|
|
UT |
|
|
|
|
SD |
SC |
|
|
NV |
|
|
|
|
|
VA |
|
|
WY |
|
|
|
|
|
WV |
|
|
|
|
Select one
Private office/small practice (10 or fewer providers) 1
Private office/large practice (11 or more providers) 2
Outpatient clinic 3
Inpatient hospital 4
Other [WRITE IN/RECORD] 5
For each option, record volunteered percentage
(Volunteered Percentage: RECORD) 1
Does not apply 2
Private health insurance
Medicaid
Medicare
Tricare or other military insurance
Other [RECORD]
Enter a number
Select one
Under 25 [TERMINATE; MOVE TO INELIGIBLE CLOSING SCRIPT] 1
25-34 years 2
35-54 years 3
55 years or older 4
Prefer not to answer 5
Yes 1
No 2
Prefer not to say [LIMIT TO 5] 3
Select all that apply
White 1
Black or African American 2
Asian 3
American Indian or Alaska Native 4
Native Hawaiian or Other Pacific Islander 5
Prefer not to answer [LIMIT TO 5] 7
Closing Scripts
ALL INTERVIEWS: Ineligible - Closing Script
[ONLINE/PHONE] I’m sorry, but you are not eligible for this study. There are many possible reasons why people are not eligible. These reasons were decided earlier by the researchers. However, thank you for your interest in this study and for taking the time to answer our questions today.
ALL INTERVIEWS: Eligible - Closing Script
The online interview will be scheduled at your convenience. Of the following dates and times [RECRUITER, PLEASE REFER TO MODERATOR AVAILABILITY SCHEDULE], which works with your schedule? [RECORD]
The discussion will be audio and video recorded, and research team members, including from the FDA, may observe the discussion so they can hear directly from you. With this additional information in mind, would you like to participate in the interview at [TIME] on [DATE] (to be determined based on the person’s availabilities as noted above)?
Yes [MOVE TO INFORMED CONSENT SCRIPT]
No
[IF NO, DON’T WANT TO PARTICIPATE] May I ask your reason for not wanting to participate? [RECORD ANSWER AND CATEGORIZE, DON’T READ OPTIONS TO RECRUIT]
Honorarium is too low
Dates/times don’t work with my schedule
Changed my mind
Declined to say
Other [WRITE IN/RECORD]
Informed Consent Instructions
Great. We will send you an informed consent form that includes more information about the study along with a reminder letter and instructions for the interview. You MUST return a signed copy of this consent form before the date of the interview to participate in it. I will email the form so you can sign, scan, and email it back.
I will send you an informed consent form by email to [EMAIL ADDRESS ON FILE]. Would you please confirm this is the best email address for you? Please read and sign the consent form and send a scanned copy of it to [EMAIL OF RECRUITER]. Please remember that to participate, we must receive the signed consent form from you before [DATE OF THE INTERVIEW].
If you have any questions about the information in the consent form, you can contact the project director, Alysia Snell, at asnell@lakeresearch.com or 202-470-4440.
File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
File Title | [no title] |
Author | hermes |
File Modified | 0000-00-00 |
File Created | 2022-07-11 |